These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38611036)

  • 21. Interventions to improve psychosocial well-being in female BRCA-mutation carriers following risk-reducing surgery.
    Jeffers L; Reid J; Fitzsimons D; Morrison PJ; Dempster M
    Cochrane Database Syst Rev; 2019 Oct; 10(10):CD012894. PubMed ID: 31595976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake and Effectiveness of Risk-Reducing Surgeries in Unaffected Female
    Zimovjanova M; Bielcikova Z; Miskovicova M; Vocka M; Zimovjanova A; Rybar M; Novotny J; Petruzelka L
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk-reducing mastectomy for the prevention of primary breast cancer.
    Carbine NE; Lostumbo L; Wallace J; Ko H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD002748. PubMed ID: 29620792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer.
    Yousefi M; Najafi S; Ghaffari S; Mahboub-Ahari A; Ghaderi H
    Iran Red Crescent Med J; 2016 May; 18(5):e23556. PubMed ID: 27437122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
    Wong CKH; Lang BHH; Yu HMS; Lam CLK
    Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the validity of estimating EQ-5D and SF-6D utility values from the health assessment questionnaire in patients with inflammatory arthritis.
    Harrison MJ; Lunt M; Verstappen SM; Watson KD; Bansback NJ; Symmons DP
    Health Qual Life Outcomes; 2010 Feb; 8():21. PubMed ID: 20149253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan.
    Nomura H; Abe A; Fusegi A; Yoshimitsu T; Misaka S; Murakami A; Matsumoto T; Tsumura S; Kanno M; Aoki Y; Netsu S; Omi M; Tanigawa T; Okamoto S; Omatsu K; Yunokawa M; Kanao H; Habano E; Arakawa H; Kaneko K; Ueki A; Haruyama Y; Inari H; Ueno T
    Sci Rep; 2023 Jan; 13(1):1018. PubMed ID: 36658289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors associated with intentions for breast cancer risk management: Does risk group matter?
    Conley CC; Agnese DM; Vadaparampil ST; Andersen BL
    Psychooncology; 2019 May; 28(5):1119-1126. PubMed ID: 30889627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the empirical validity of alternative multi-attribute utility measures in the maternity context.
    Petrou S; Morrell J; Spiby H
    Health Qual Life Outcomes; 2009 May; 7():40. PubMed ID: 19419553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk-reducing surgery in BRCA1/BRCA2 mutation carriers: Are there factors associated with the choice?
    Manoukian S; Alfieri S; Bianchi E; Peissel B; Azzollini J; Borreani C
    Psychooncology; 2019 Sep; 28(9):1871-1878. PubMed ID: 31264307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding the relationship between the EQ-5D, SF-6D, HAQ and disease activity in inflammatory arthritis.
    Adams R; Walsh C; Veale D; Bresnihan B; FitzGerald O; Barry M
    Pharmacoeconomics; 2010; 28(6):477-87. PubMed ID: 20465316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
    Domchek SM; Friebel TM; Singer CF; Evans DG; Lynch HT; Isaacs C; Garber JE; Neuhausen SL; Matloff E; Eeles R; Pichert G; Van t'veer L; Tung N; Weitzel JN; Couch FJ; Rubinstein WS; Ganz PA; Daly MB; Olopade OI; Tomlinson G; Schildkraut J; Blum JL; Rebbeck TR
    JAMA; 2010 Sep; 304(9):967-75. PubMed ID: 20810374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesterol profile in women with premature menopause after risk reducing salpingo-oophorectomy.
    Teixeira N; Mourits MJ; Oosterwijk JC; Fakkert IE; Absalom AR; Bakker SJL; van der Meer P; de Bock GH
    Fam Cancer; 2019 Jan; 18(1):19-27. PubMed ID: 29881922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Morbidity and Health After Early Menopause Due to Oophorectomy in Women at Increased Risk of Ovarian Cancer: Protocol for a Nationwide Cross-Sectional Study With Prospective Follow-Up (HARMOny Study).
    Terra L; Hooning MJ; Heemskerk-Gerritsen BAM; van Beurden M; Roeters van Lennep JE; van Doorn HC; de Hullu JA; Mom C; van Dorst EBL; Mourits MJE; Slangen BFM; Gaarenstroom KN; Zillikens MC; Leiner T; van der Kolk L; Collee M; Wevers M; Ausems MGEM; van Engelen K; Berger LP; van Asperen CJ; Gomez-Garcia EB; van de Beek I; Rookus MA; Hauptmann M; Bleiker EM; Schagen SB; Aaronson NK; Maas AHEM; van Leeuwen FE
    JMIR Res Protoc; 2021 Jan; 10(1):e24414. PubMed ID: 33480862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sexuality and quality of life in women with a prior diagnosis of breast cancer after risk-reducing salpingo-oophorectomy.
    Tucker PE; Saunders C; Bulsara MK; Tan JJ; Salfinger SG; Green H; Cohen PA
    Breast; 2016 Dec; 30():26-31. PubMed ID: 27592287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.
    Grandi G; Sammarini M; Cortesi L; Toss A; Botticelli L; Varliero F; Sighinolfi G; Barbieri E; Facchinetti F
    Menopause; 2021 Feb; 28(3):263-270. PubMed ID: 33534430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 or BRCA2 mutation carriers: A systematic review and meta-analysis.
    Wang Y; Song Z; Zhang S; Wang X; Li P
    Eur J Surg Oncol; 2022 Jun; 48(6):1209-1216. PubMed ID: 35216860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.